Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) reached a new 52-week high during trading on Tuesday . The stock traded as high as $95.65 and last traded at $94.19, with a volume of 419660 shares trading hands. The stock had previously closed at $93.42. Analyst Upgrades and Downgrades A number of analysts have commented on […]
Exact Sciences Corp (NASDAQ: EXAS) shares are rising in extended trading Tuesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced positive top-line results...
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price target […]
Exact Sciences (NASDAQ:EXAS – Get Rating) and CareDx (NASDAQ:CDNA – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings. Earnings and Valuation This table compares Exact Sciences and CareDx’s revenue, […]